InnoCon Medical will participate in the ICS 2023 Toronto7. September 2023
Adding Two International Recognised Sites for Clinical Testing of UCon – Maastricht UMC (NL) and Vall d’Hebron (ES)30. November 2023
InnoCon Medical has achieved another milestone in its development. Our innovative device UCon, has received approval from the Danish Medicines Agency and Danish Medical Research Ethics Committees to initiate clinical investigations with our Bar Electrode. The Bar Electrode is a “permanent percutaneous” electrode placed close to the dorsal genital nerve, enabling specific neural mechanisms acting on overactive bladder (OAB) and fecal incontinence (FI). The study will be performed together with our long-term clinical partners from Aarhus University Hospital, Odense University Hospital, and Herlev Hospital. The clinical study is co-funded by Innovation Fund Denmark.